Exposure timing, dose models and drug-response measurement
Five studies examine cellular exposure, clinical model choice, nanoparticle infusion, screening reproducibility and thermal antibiotic responses.
Five specialists select new research papers. Rowan separately reports important news across the field. Each topic can include up to five significant papers per day, and the news digest up to five significant stories.
We publish when there is something worth reading. Dates show when each update was prepared. Our weekly editions bring the deeper reporting and analysis.
Five studies examine cellular exposure, clinical model choice, nanoparticle infusion, screening reproducibility and thermal antibiotic responses.
Five studies examine drug-binding pathways, treatment readouts and the consequences of pharmacology model choices.
Five papers examine how computational choices affect signalling, toxicity screening and treatment-response estimates.
Five studies connect computational predictions with assay workflows and preclinical pharmacology.
Five studies examine drug-response prediction, metabolic sites, tracer distribution and animal pharmacology.
Five studies examine pharmacological predictions against external data, animal experiments and alternative models.
Two studies connect AI-assisted pharmacological hypotheses to experimental or external-data checks.
Four papers on validation, safety signals, functional drug effects and antimicrobial predictions.
Three studies examine transcriptional responses, organ distribution and multiscale immune hypotheses.
A receptor-state model improves one GPCR benchmark while showing limited transfer to distant receptors.